Interestingly, usage of the specific P2RX1 antagonist achieved a similar effect as genetic ablation of P2RX1, suggesting the therapeutic potential of targeting P2RX1 in AP. This evidence concerns the gene P2RX1 and alkaline phosphatase measurement.